Timothy Kieffer
Director Técnico/Científico/I+D en FRACTYL HEALTH, INC. .
Fortuna: - $ al 30/06/2024
Cargos activos de Timothy Kieffer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FRACTYL HEALTH, INC. | Director Técnico/Científico/I+D | 01/09/2023 | - |
Historial de carrera de Timothy Kieffer
Antiguos cargos conocidos de Timothy Kieffer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/09/2021 | 01/10/2022 |
| University of British Columbia | Corporate Officer/Principal | 01/01/2007 | - |
Formación de Timothy Kieffer.
| University of British Columbia | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FRACTYL HEALTH, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Timothy Kieffer
- Experiencia
